Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
Radiotherapy for Oligometastatic Prostate Cancer
|4||Active, not recruiting||
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
† Study has passed its completion date and status has not been verified in more than two years.